143 related articles for article (PubMed ID: 21452004)
1. MRI internal segmentation of optic pathway gliomas: clinical implementation of a novel algorithm.
Shofty B; Weizman L; Joskowicz L; Constantini S; Kesler A; Ben-Bashat D; Yalon M; Dvir R; Freedman S; Roth J; Ben-Sira L
Childs Nerv Syst; 2011 Aug; 27(8):1265-72. PubMed ID: 21452004
[TBL] [Abstract][Full Text] [Related]
2. Automatic segmentation, internal classification, and follow-up of optic pathway gliomas in MRI.
Weizman L; Ben Sira L; Joskowicz L; Constantini S; Precel R; Shofty B; Ben Bashat D
Med Image Anal; 2012 Jan; 16(1):177-88. PubMed ID: 21852179
[TBL] [Abstract][Full Text] [Related]
3. Automatic segmentation and components classification of optic pathway gliomas in MRI.
Weizman L; Ben-Sira L; Joskowicz L; Precel R; Constantini S; Ben-Bashat D
Med Image Comput Comput Assist Interv; 2010; 13(Pt 1):103-10. PubMed ID: 20879220
[TBL] [Abstract][Full Text] [Related]
4. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
[TBL] [Abstract][Full Text] [Related]
5. Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components.
Bennebroek CA; Schouten CR; Montauban-van Swijndregt MC; Saeed P; Porro GL; Pott JWR; Dittrich ATM; Oostenbrink R; Schouten-van Meeteren AY; de Jong MC; de Graaf P
J Neurooncol; 2024 Jan; 166(1):79-87. PubMed ID: 38150061
[TBL] [Abstract][Full Text] [Related]
6. Optic pathway gliomas in adults.
Shofty B; Constantini S; Bokstein F; Ram Z; Ben-Sira L; Freedman S; Vainer G; Kesler A
Neurosurgery; 2014 Mar; 74(3):273-9; discussion 279-80. PubMed ID: 24335817
[TBL] [Abstract][Full Text] [Related]
7. Automatic segmentation, classification, and follow-up of optic pathway gliomas using deep learning and fuzzy c-means clustering based on MRI.
Artzi M; Gershov S; Ben-Sira L; Roth J; Kozyrev D; Shofty B; Gazit T; Halag-Milo T; Constantini S; Ben Bashat D
Med Phys; 2020 Nov; 47(11):5693-5701. PubMed ID: 32969025
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
Thiagalingam S; Flaherty M; Billson F; North K
Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
[TBL] [Abstract][Full Text] [Related]
9. Can we improve accuracy and reliability of MRI interpretation in children with optic pathway glioma? Proposal for a reproducible imaging classification.
Lambron J; Rakotonjanahary J; Loisel D; Frampas E; De Carli E; Delion M; Rialland X; Toulgoat F
Neuroradiology; 2016 Feb; 58(2):197-208. PubMed ID: 26518314
[TBL] [Abstract][Full Text] [Related]
10. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S
Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Conventional and Dynamic Contrast-Enhanced MRI in Optic Pathway Gliomas.
Jittapiromsak N; Hou P; Liu HL; Sun J; Slopis JM; Chi TL
J Neuroimaging; 2017 Nov; 27(6):594-601. PubMed ID: 28524459
[TBL] [Abstract][Full Text] [Related]
12. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE; Nuding MA
Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
[TBL] [Abstract][Full Text] [Related]
13. Semiautomatic segmentation and follow-up of multicomponent low-grade tumors in longitudinal brain MRI studies.
Weizman L; Sira LB; Joskowicz L; Rubin DL; Yeom KW; Constantini S; Shofty B; Bashat DB
Med Phys; 2014 May; 41(5):052303. PubMed ID: 24784396
[TBL] [Abstract][Full Text] [Related]
14. Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.
Avery RA; Mansoor A; Idrees R; Trimboli-Heidler C; Ishikawa H; Packer RJ; Linguraru MG
Neurology; 2016 Dec; 87(23):2403-2407. PubMed ID: 27815398
[TBL] [Abstract][Full Text] [Related]
15. The effect of chemotherapy on optic pathway gliomas and their sub-components: A volumetric MR analysis study.
Shofty B; Mauda-Havakuk M; Weizman L; Constantini S; Ben-Bashat D; Dvir R; Pratt LT; Joskowicz L; Kesler A; Yalon M; Ravid L; Ben-Sira L
Pediatr Blood Cancer; 2015 Aug; 62(8):1353-9. PubMed ID: 25858021
[TBL] [Abstract][Full Text] [Related]
16. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226
[TBL] [Abstract][Full Text] [Related]
17. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.
de Blank PMK; Fisher MJ; Liu GT; Gutmann DH; Listernick R; Ferner RE; Avery RA
J Neuroophthalmol; 2017 Sep; 37 Suppl 1(Suppl 1):S23-S32. PubMed ID: 28806346
[TBL] [Abstract][Full Text] [Related]
18. Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.
Avery RA; Mansoor A; Idrees R; Biggs E; Alsharid MA; Packer RJ; Linguraru MG
Neurology; 2016 Jun; 86(24):2264-70. PubMed ID: 27170570
[TBL] [Abstract][Full Text] [Related]
19. Isolated optic nerve gliomas: a multicenter historical cohort study.
Shofty B; Ben-Sira L; Kesler A; Jallo G; Groves ML; Iyer RR; Lassaletta A; Tabori U; Bouffet E; Thomale UW; Hernáiz Driever P; Constantini S;
J Neurosurg Pediatr; 2017 Dec; 20(6):549-555. PubMed ID: 28984541
[TBL] [Abstract][Full Text] [Related]
20. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
